Based on the Novartis AG ADR stock forecast from 3 analysts, the average analyst target price for Novartis AG ADR is USD 123.38 over the next 12 months. Novartis AG ADR’s average analyst rating is Buy . Stock Target Advisor’s own stock analysis of Novartis AG ADR is Neutral, which is based on 1 positive signals and 1 negative signals. At the last closing, Novartis AG ADR’s stock price was USD 110.52. Novartis AG ADR’s stock price has changed by -4.42% over the past week, -3.01% over the past month and -40.43% over the last year.
No recent analyst target price found for Novartis AG ADR
No recent average analyst rating found for Novartis AG ADR
Company Overview Novartis AG ADR
N/A
N/A
N/A
N/A
USD
USA
Adjusted Closing Price for Novartis AG ADR (NVS)
Loading...
Unadjusted Closing Price for Novartis AG ADR (NVS)
Frequently Asked Questions About Novartis AG ADR (NVS) Stock
Based on ratings from 3 analysts Novartis AG ADR's stock is Buy . Stock Target Advisor's fundamental analysis is Neutral. The stock has 2 buy, sell and 2 hold ratings.
Unfortunately we do not have enough data on NVS's stock to indicate if its a good dividend stock.
Based on targets from 3 analysts, the average taret price for NVS is USD 123.38 over the next 12 months. The maximum analyst target price is USD 130 while the minimum anlayst target price is USD 120.
Unfortunately we do not have enough data on NVS's stock to indicate if its overvalued.
The last closing price of NVS's stock was USD 110.52.
Unfortunately we do not currently have any market capitalization data for NVS's stock.
Based on targets from 3 analysts, the average taret price for NVS is projected at USD 123.38 over the next 12 months.
This means that NVS's stock price may go up by +11.63% over the next 12 months.
We can't find any ETFs which contains Novartis AG ADR's stock.
Sorry, we do not have any data on the number of employees for Novartis AG ADR.
Sorry we do not have any infomation available on Novartis AG ADR's address.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Low volatility
The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.
What not to like
Low Revenue Growth
This stock has shown below median revenue growth in the previous 5 years compared to its sector
Frequently Asked Questions About Novartis AG ADR (NVS) Stock
Based on ratings from 3 analysts Novartis AG ADR's stock is Buy . Stock Target Advisor's fundamental analysis is Neutral. The stock has 2 buy, sell and 2 hold ratings.
Unfortunately we do not have enough data on NVS's stock to indicate if its a good dividend stock.
Based on targets from 3 analysts, the average taret price for NVS is USD 123.38 over the next 12 months. The maximum analyst target price is USD 130 while the minimum anlayst target price is USD 120.
Unfortunately we do not have enough data on NVS's stock to indicate if its overvalued.
The last closing price of NVS's stock was USD 110.52.
Unfortunately we do not currently have any market capitalization data for NVS's stock.
Based on targets from 3 analysts, the average taret price for NVS is projected at USD 123.38 over the next 12 months.
This means that NVS's stock price may go up by +11.63% over the next 12 months.
We can't find any ETFs which contains Novartis AG ADR's stock.
Sorry, we do not have any data on the number of employees for Novartis AG ADR.
Sorry we do not have any infomation available on Novartis AG ADR's address.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for NVS !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
